retatrutide triple agonist glp-1 gip glucagon phase 3 2025 Lilly Prepares for FDA Filing Following Additional Data in Diabetes, CVD Retatrutide: The GLP-1/GIP/Glucagon Triple-Agonist Guide
Pay in 4 interest-free payments of $6.13 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24


























